|
Characterization of tumor-associated B cell subsets in head and neck squamous cell carcinoma. |
|
|
Consulting or Advisory Role - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst) |
Speakers' Bureau - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche Pharma AG |
Research Funding - Astellas Pharma (Inst); Roche Pharma AG (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Boehringer Ingelheim; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma |
|
|
No Relationships to Disclose |
|
Alexander Shimabukuro-Vornhagen |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Michael S von Bergwelt-Baildon |
No Relationships to Disclose |